Zinc in depression: a meta-analysis W Swardfager, N Herrmann, G Mazereeuw, K Goldberger, T Harimoto, ... Biological psychiatry 74 (12), 872-878, 2013 | 302 | 2013 |
A programmable encapsulation system improves delivery of therapeutic bacteria in mice T Harimoto, J Hahn, YY Chen, J Im, J Zhang, N Hou, F Li, C Coker, K Gray, ... Nature Biotechnology 40 (8), 1259-1269, 2022 | 155 | 2022 |
Enhancing the tropism of bacteria via genetically programmed biosensors T Chien, T Harimoto, B Kepecs, K Gray, C Coker, N Hou, K Pu, T Azad, ... Nature biomedical engineering 6 (1), 94-104, 2022 | 101 | 2022 |
Respiratory‐related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005–2012) compared to other international registries B Paes, I Mitchell, A Li, T Harimoto, KL Lanctôt Journal of Immunology Research 2013 (1), 917068, 2013 | 54 | 2013 |
Predictors of readmission to a psychiatry inpatient unit J Moss, A Li, J Tobin, IS Weinstein, T Harimoto, KL Lanctôt Comprehensive Psychiatry 55 (3), 426-430, 2014 | 52 | 2014 |
Rapid screening of engineered microbial therapies in a 3D multicellular model T Harimoto, ZS Singer, OS Velazquez, J Zhang, S Castro, TE Hinchliffe, ... Proceedings of the National Academy of Sciences 116 (18), 9002-9007, 2019 | 44 | 2019 |
Outcomes of infants receiving palivizumab prophylaxis for respiratory syncytial virus in Canada and Italy: an international, prospective cohort study P Manzoni, B Paes, KL Lanctôt, A Dall’Agnola, I Mitchell, S Calabrese, ... The Pediatric infectious disease journal 36 (1), 2-8, 2017 | 35 | 2017 |
Risk factors for progression of Alzheimer disease in a Canadian population: the Canadian Outcomes Study in Dementia (COSID) N Herrmann, T Harimoto, R Balshaw, KL Lanctôt, ... The Canadian Journal of Psychiatry 60 (4), 189-199, 2015 | 35 | 2015 |
Bacterial therapies at the interface of synthetic biology and nanomedicine J Hahn, S Ding, J Im, T Harimoto, KW Leong, T Danino Nature Reviews Bioengineering 2 (2), 120-135, 2024 | 32 | 2024 |
Injectable therapeutic organoids using sacrificial hydrogels NS Rossen, PN Anandakumaran, R Zur Nieden, K Lo, W Luo, C Park, ... Iscience 23 (5), 2020 | 22 | 2020 |
Engineering bacteria for cancer therapy T Harimoto, T Danino Emerging topics in life sciences 3 (5), 623-629, 2019 | 19 | 2019 |
A rapid screening platform to coculture bacteria within tumor spheroids T Harimoto, D Deb, T Danino Nature protocols 17 (10), 2216-2239, 2022 | 17 | 2022 |
Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer D Deb, Y Wu, C Coker, T Harimoto, R Huang, T Danino Scientific Reports 12 (1), 21551, 2022 | 8 | 2022 |
Multiplexed biosensors for precision bacteria tropism in vivo T Chien, T Harimoto, B Kepecs, K Gray, C Coker, K Pu, T Azad, T Danino bioRxiv, 851311, 2019 | 6 | 2019 |
Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug AR Decker-Farrell, SA Sastra, T Harimoto, MC Hasselluhn, CF Palermo, ... bioRxiv, 2024.05. 02.592216, 2024 | 2 | 2024 |
A programmable probiotic encapsulation system enhances therapeutic delivery in vivo T Harimoto, J Hahn, YY Chen, J Im, J Zhang, N Hou, F Li, C Coker, K Gray, ... bioRxiv, 2021.08. 03.454638, 2021 | 2 | 2021 |
Reprogramming the proteome for cell-free protein expression T Harimoto Synthetic Biology 5 (1), ysaa013, 2020 | 1 | 2020 |
Programmable Nanoencapsulation for Delivery of Probiotics in Vivo T Danino, K Leong, T Harimoto, J Hahn US Patent App. 18/498,383, 2024 | | 2024 |
Abstract B015: Toxin-producing bacterial therapy limits tumor growth in autochthonous mouse models of pancreatic ductal adenocarcinoma AR Decker-Farrell, SA Sastra, T Harimoto, MC Hasselluhn, F Li, R Vincent, ... Cancer Research 84 (2_Supplement), B015-B015, 2024 | | 2024 |
Toxin-producing bacterial therapy limits tumor growth in autochthonous mouse models of pancreatic ductal adenocarcinoma AR Decker-Farrell, SA Sastra, T Harimoto, MC Hasselluhn, F Li, R Vincent, ... CANCER RESEARCH 84 (2), 2024 | | 2024 |